Evidence map›Paper›PMID 37239341›Full record

ArticleGenes2023

Andrea Latini, Giada De Benedittis, Serena Colafrancesco, Carlo Perricone, Giuseppe Novelli, Lucia Novelli, Roberta Priori, Cinzia Ciccacci, Paola Borgiani

Open access · goldAbstract read
In one paragraph

Article in Genes, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.4field-weighted citation impact, top 41% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 2 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 5 institutions in 2 countries.

Andrea LatiniDepartment of Biomedicine and Prevention, Genetics Section, University of Rome Tor Vergata, 00133 Rome, Italy.ORCID 0000-0002-5350-7361
Giada De BenedittisDepartment of Biomedicine and Prevention, Genetics Section, University of Rome Tor Vergata, 00133 Rome, Italy.
Serena ColafrancescoDivision of Rheumatology, Department of Clinical Internal, Anaesthesiologic and Cardiovascular Sciences, Sapienza University, 00133 Rome, Italy.
Carlo PerriconeRheumatology, Department of Medicine, University of Perugia, Piazzale Giorgio Menghini 1, 06129 Perugia, Italy.ORCID 0000-0003-4771-6981
Giuseppe NovelliDepartment of Biomedicine and Prevention, Genetics Section, University of Rome Tor Vergata, 00133 Rome, Italy.ORCID 0000-0002-7781-602X
Lucia NovelliUniCamillus, Saint Camillus International University of Health Sciences, 00131 Rome, Italy.
Roberta PrioriUniCamillus, Saint Camillus International University of Health Sciences, 00131 Rome, Italy.
Cinzia CiccacciUniCamillus, Saint Camillus International University of Health Sciences, 00131 Rome, Italy.ORCID 0000-0002-3995-7032
Paola BorgianiDepartment of Biomedicine and Prevention, Genetics Section, University of Rome Tor Vergata, 00133 Rome, Italy.
University of Rome Tor Vergata · ITSaint Camillus International University of Health and Medical Sciences · ITPoliclinico Umberto I · ITSapienza University of Rome · ITUniversity of Perugia · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe

methodsWe investigated the

resultsWe observed, by RT-qPCR, that the

conclusionsOur data suggest that Furin could play a role in SS development, also promoting IFN-γ secretion.

Indexed as

FurinSjogren's SyndromeGene ExpressionHumansInterferon-gammaLeukocytes, MononuclearPromoter Regions, GeneticFurinFURIN protein, humanInterferon-gammaIFN-γPCSK3Sjögren’s syndrome

Identifiers

PMID37239341
PMCPMC10217834
OpenAlexW4367182075

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.